| |
|
|
|
Immucell Cp  
|
|
5.7 0.12 (0.02%) |
08-10 16:00 |
|
Open: |
5.68 |
Pre close: |
5.58 |
Target:
|
6.96
|
|
High: |
5.7 |
Low: |
5.43 |
Resistance:
|
5.96
6.56
|
|
Volume: |
5,045 |
Market Cap: |
41M |
Support:
|
4.98
4.14
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.62
 |
MACD |
MACD(12,26):
|
0.08 |
|
MA(20): |
5.80  |
Signal(12,26,9): |
0.14 |
|
MA(100): |
4.75 |
Stochastic Oscillator |
%K(14,3):
|
48.15 |
|
MA(250): |
5.01 |
%D(3): |
45.93 |
|
Average Volume(K) |
3-Month: |
3326
|
52-Week |
High:
|
8.13 |
|
10-Days: |
1800 |
Low: |
3.70 |
|
RSI |
RSI(14):
|
53.65 |
Change(%): |
-5.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.220 |
Return on Equity (ttm) |
-5.3 |
Shares Out. (M) |
7.21 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-1.6 |
Shares Float (M) |
5.16 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
28.40 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
11.3 |
% Held by Institutions |
20.36 |
|
Forward EPS |
-0.030 |
Gross Profit (p.s.) |
0.935 |
Shares Short (K) |
15 |
|
Book Value (p.s.) |
4.020 |
EBITDA (p.s.) |
0.172 |
P/E |
-25.91 |
|
Sales Per Share |
1.972 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.42 |
|
Profit Margin |
-10.98 |
Operating Cash Flow
(M) |
0.41 |
P/S |
2.89 |
|
Operating Margin |
-7.19 |
Levered Free Cash Flow
(M) |
-0.68 |
P/CF |
99.32 |
|
|
|
|
|
|
